Predictors of advanced fibrosis among NASH patients vary by study, but commonly include age, metabolic syndrome-associated factors (obesity, the presence of insulin resistance, diabetes mellitus, hypertension, and hypertriglycemia), and elevated ALT level [7,39,40]. This evidence concerns the gene GPT and metabolic dysfunction-associated steatohepatitis.